Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer&apos;s Disease: Data from the Zab&#250;t Aging Project by Panzarella, Vera et al.
Journal of Alzheimer’s Disease xx (20xx) x–xx
DOI 10.3233/JAD-200385
IOS Press
1
Oral Health Status in Subjects with
Amnestic Mild Cognitive Impairment
and Alzheimer’s Disease: Data from
the Zabu´t Aging Project
Vera Panzarellaa,1, Rodolfo Mauceria,1, Roberta Baschib, Laura Maniscalcob,
Giuseppina Campisia and Roberto Monasterob,∗
aDepartment of Surgical, Oncological, and Oral Sciences, Sector of Oral Medicine “Valerio Margiotta”;
University of Palermo, Palermo, Italy
bDepartment of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Palermo, Italy
Accepted 16 April 2020
Abstract.
Background: The relationship between Alzheimer’s disease (AD) and periodontitis has been recently investigated with
heterogenous results.
Objective: This study aims to evaluate the oral health status and its relationship with cognitive impairment of participants,
enrolled in the Zabu´t Aging Project, a community-based cohort study performed in a rural community in Sicily, Italy.
Methods: A case-control study (20 subjects with AD, 20 with amnestic mild cognitive impairment [aMCI], and 20 controls)
was conducted. The protocol included a comprehensive medical and cognitive-behavioral examination. Full-mouth evaluation,
microbial analysis of subgingival plaque samples (by RT-PCR analysis), and oral health-related quality of life (OHR-QoL)
were evaluated.
Results: The decayed, missing, and filled teeth (DMFT) total score of AD subjects was significantly higher than aMCI
(p = 0.009) and controls (p = 0.001). Furthermore, the “M” component of DMFT (i.e., the number of missing teeth) was
significantly higher in AD than in aMCI (p < 0.001) and controls (p < 0.001). A Poisson regression model revealed that age
(p < 0.001), male gender (p = 0.001), and AD (p = 0.001) were positively correlated with DMFT. Concerning oral microbial
load, the presence of Fusobacterium nucleatum was significantly higher in AD than in controls (p = 0.02), and a higher load
of Treponema denticola was found in aMCI than with AD (p = 0.004). OHR-QoL scores did not differ among the groups.
Conclusion: The current research suggests that AD is associated with chronic periodontitis, which is capable of determining
tooth loss due to the pathogenicity of Fusobacterium nucleatum. These data remain to be confirmed in larger population-based
cohorts.
Keywords: Alzheimer’s disease, cognitive impairment, epidemiology, oral health, periodontitis, tooth loss
1These authors contributed equally to this work.
∗Correspondence to: Prof. Roberto Monastero, MD, PhD,
Department of Biomedicine, Neuroscience and advanced Diag-
nostics, University of Palermo, Palermo, Italy, Via La Loggia
1, 90129 Palermo, Italy. Tel./Fax: +39 091 655.5185; E-mails:
roberto.monastero@unipa.it and roberto.monastero@gmail.com
INTRODUCTION
The improvement in general health, observed in
recent decades, has promoted life expectancy at birth
of the world’s population. According to previsions,
the percentage of people over 65 years of age will
increase from 12% to 22% in developed countries
ISSN 1387-2877/20/$35.00 © 2020 – IOS Press and the authors. All rights reserved
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[1, 2]. Since elderly populations are rising, the inci-
dence of dementia and cognitive impairment has
become a public health challenge.
Dementia is a common and disabling disorder;
the World Health Organization (WHO) has estimated
that 47.5 million people worldwide in 2015 suffered
from dementia [1]; in Italy there are more than 1
million individuals affected by dementia [3]. Demen-
tia is the main cause of cognitive impairment in the
elderly, and it is usually associated with memory
loss, judgment impairment, changes in personality,
mood, and behavior, all of which lead to diffi-
culty in performing day-to-day activities and familiar
tasks. The major cause of dementia is Alzheimer’s
disease (AD), a progressive neurodegenerative disor-
der accounting for 60–70% of all dementias [3, 4].
The disease is mostly sporadic (>95% of all cases)
and results from the interaction of multiple genetic
and environmental factors. Its prevalence spreads
with age, increasing from 3% in subjects aged 65
years or over, doubling every 5 years after 65 years
[3–5].
Mild cognitive impairment (MCI) is a clinical syn-
drome considered a prodromal phase of AD [6].
Subjects with MCI are not functionally impaired
in everyday activities but they develop difficulty
with memory, language, or other cognitive functions,
and frequently show behavioral abnormalities [7, 8].
MCI with positive AD biomarkers [9], the so-called
MCI due to AD, frequently show a prominent mem-
ory impairment. The latter is defined as amnestic
MCI (aMCI), and it usually progresses to overt AD
dementia [7].
A possible relationship between AD and oral
health has been widely investigated, and many condi-
tions related to poor oral health have been proposed
as risk factors for the development of AD [10–13].
Subjects with MCI and AD have also been found to
have a higher risk of developing severe periodontitis,
tooth loss with impaired chewing capability [14–17].
Periodontitis is a local, chronic inflammatory disease
with potential systemic effects [18], and, with dental
caries, it is a major cause of tooth loss especially in
elderly subjects [19–21].
Chronic periodontitis is associated with ele-
vated blood levels of pro-inflammatory cytokines,
such as IL-1, IL-6, and TNF-, which may
induce a low-grade, persistent, systemic inflamma-
tion, thus stimulating the peripheral nerves [11,
22–24]. Additionally, periodontal bacteria, such as
Porphyromonas gingivalis, Treponema forsythia, and
Treponema denticola, may penetrate the bloodstream
and infect organs directly or generate inflammatory
reactions [5, 25, 26].
The aim of this study was to investigate the oral
health status of subjects with aMCI and AD, drawn
from a population-based cohort study, which had
been conducted in rural subjects from southern Italy.
The specific aims of the study were to: 1) evalu-
ate dental status and characteristics in subjects with
aMCI and AD compared to controls; 2) evaluate
periodontal status and oral microbial load in aMCI
and AD in comparison to controls; 3) determine
oral health-related quality of life (OHR-QoL) among
the three study groups; and 4) identify the relation-
ships between cognitive impairment and poor oral
health.
MATERIALS AND METHODS
Subject recruitment
A case-control study including 60 subjects (20
AD, 20 aMCI, and 20 cognitively normal individ-
uals without cognitive and functional impairment
[CONS]), sharing similar demographic characteris-
tics, has been conducted. Participants were recruited
during the 10-year follow-up of the Zabu´t Aging
Project (ZAP), a population-based cohort study con-
ducted in a rural community with a low educational
level in the province of Agrigento (Sicily, Italy).
All subjects were examined in accordance with
a comprehensive standardized protocol, including:
physical, neurological, and psychiatric examina-
tions; past and present comorbidities and medication.
Finally, a comprehensive neuropsychological bat-
tery, including tests of global cognition, in addition
to tasks evaluating specific cognitive domains (i.e.,
memory, language, attentive/visuo-constructional
abilities, and executive functioning) were adminis-
tered to all participants by psychologists trained in
neuropsychology [27].
The diagnosis of dementia was ascertained by spe-
cialists according to the DSM-IV-TR criteria [28]
and probable AD was diagnosed according to the
National Institute on Aging and the Alzheimer’s
Association criteria [29]. aMCI was defined accord-
ing to modified Petersen’s criteria [6]. Global
cognition was assessed with the Italian version of
the Mini-Mental State Examination (MMSE) (age-
, gender-, and education-adjusted cut-off points)
[30]. Functional status was evaluated with the basic
and instrumental activities of daily living (ADL
and IADL) tools [31, 32]. Depressive symptoms
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were assessed with the Center for Epidemiologic
Studies-Depression scale (CES-D), which is a short
self-report scale designed to measure depressive
symptoms in the general population [33].
In order to exclude vascular cognitive impairment,
subjects with aMCI and AD also underwent a routine
1.5T MRI scan (Signa HDxt; GE Medical System,
Milwaukee, WI, USA). The MRI protocol employed
included the following sequences: sagittal and axial
T2w Fast Recovery Fast Spin Echo, axial and coronal
T2w FLAIR, axial T1w FSE, axial T2∗w Gradi-
ent Echo, and axial Echo-Planar Diffusion-Weighted
Imaging. The axial plane for these analyses was paral-
lel to the anterior commissure–posterior commissure
line, the coronal plane was parallel to the brainstem,
and the sagittal plane was parallel to the interhemi-
spheric fissure. MRI images were evaluated by an
experienced neuro-radiologist, who was blind to the
clinical diagnoses.
Lifestyles, vascular comorbidity, and
biochemical/genetic parameters
Data regarding smoking and alcohol drinking were
obtained by questioning the subjects or caregivers
(in the case of a cognitively impaired or demented
subject). For the current analyses, subjects were
dichotomized into current smokers (subject smok-
ing at least five cigarettes daily during the last 5
years) versus never/former smokers (subjects who
had never smoked or had smoked and stopped at
least 5 years prior to observation). Alcohol drinking
was classified into two categories: never/infrequent
drinkers (persons who never drink or who drank
alcohol less than once a week) versus frequent
drinkers (persons who drink alcohol at least once
a week).
The following vascular comorbidities were
assessed, as previously described [34]:
– obesity was evaluated using body mass index
(BMI, with values ≥30 kg/m2). BMI was also
used as a continuous variable and was consid-
ered as an indirect indicator of malnutrition in
the elderly [35];
– hypertension (current use of antihypertensive
medications or blood pressure ≥140/90 mmHg);
– dyslipidemia [fasting Total Cholesterol
(TC) ≥240 mg/dL and/or triglycerides (TG)
≥150 mg/dL, and/or HDL < 40 mg/dL in
men and <50 mg/dL in women, and/or LDL
≥ 160 mg/dL];
– diabetes mellitus (current use of hypoglycemic
drugs and/or fasting blood glucose levels
≥110 mg/dL);
– atrial fibrillation and ischemic heart disease
(angina, myocardial infarction, coronary artery
bypass grafting, or angioplasty or stenting),
as supported by clinical and/or instrumental
records.
A venous blood sampling was obtained in the
morning after an overnight fast to establish bio-
chemical and genetic parameters. High sensitivity
C-reactive protein was measured by a chemilumi-
nescent immunoassay (Immulite, Medical Systems,
Italy), used as an indicator of systemic inflammation.
The apolipoprotein E (APOE) genotype was deter-
mined from blood leukocytes. DNA was extracted by
a standardized method, and APOE genotypes were
analyzed by a polymerase chain reaction, as previ-
ously described [36]. All analyses were conducted
comparing E4-carrying (E2/E4, E3/E4, E4/E4) ver-
sus non-E4 carrying genotypes.
The study agreed with the principles outlined
in the Helsinki declaration, and written informed
consent was obtained from all participants or
their caregiver after the procedures had been fully
explained. The ethical committee ASP-1 (“Azienda
Sanitaria Provinciale”, i.e., provincial health author-
ity) of Agrigento, Italy approved the ZAP protocol.
Furthermore, general authorization relating to the
genetic data treatment was provided by the Italian
Data Protection Authority (code: 0000-0326-7509-
4804).
Assessment of dental status and bacterial load
All participants (n = 60) underwent a complete
assessment of oral health status. Oral examinations
were performed at the patients’ home by a trained
oral professional using mirrors, a dental probe, and
intra-oral light. The findings were recorded on a stan-
dardized screening sheet. The initial data collection
regarded an evaluation of dental status according
to the Decayed, Missing, and Filled Teeth (DMFT)
index [37]. The latter index is applied to the perma-
nent dentition, being expressed as the total number of
teeth which are decayed (D), missing (M), or filled
(F); scores per individual can range from 0 to 28 or 32,
depending on whether the third molars are included
in the scoring (i.e., higher score are related to poorer
oral status). The Community Periodontal Index (CPI)
and the Periodontal Screening and Recording (PSR)
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were used [37, 38] to assess the periodontal status of
the enrolled subjects, following the recommendation
of WHO for community-based screening programs.
The two indices use a common evaluation method,
based on the following three periodontal disease
indicators: gingival bleeding on probing (BoP) cal-
culus accumulation; and probing depth. Additionally,
the PSR Index provides a more detailed picture of
periodontal status by recording the presence of fur-
cation involvement, tooth mobility, muco-gingival
problems, and gingival recessions exceeding 3.5 mm.
The data were collected and scored by dividing the
mouth into six sextants, and each tooth into six differ-
ent sites: mesiobuccal, midbuccal, distobuccal; and
the corresponding lingual or palatal sites. Each tooth
was scored from Code 0 to Code 4 but only the
highest score of the sextant was recorded. Overall,
the following oral parameters (i.e., bleeding or BoP,
tooth mobility, orofacial pain, dental abscess, hali-
tosis, and calculus) were collected (presence versus
absence).
Thereafter, all subjects underwent a sampling
of the sub-gingival plaque bacterial load (using a
Carpegen® Perio Diagnostics kit with paper cones
on gingival crevicular fluid) in order to perform an
RT-PCR analysis for the quantitative determination of
six marker organisms of periodontitis: Aggregatibac-
ter actinomycetemcomitans (A.a), Fusobacterium
nucleatum (F.n.), Porphyromonas gingivalis (P.g.),
Prevotella intermedia (P.i.), Treponema denticola
(T.d.), and Tannerella forsythia (T.f.).
Finally, the OHR-QoL was evaluated using the
Short Form Oral Health Impact Profile (OHIP-14)
[39], a self-filled questionnaire useful to assess the
impact of chronic oral problems on the patients’
everyday life. The OHIP-14 includes 14 items and
7 subscales regarding the following dimensions:
functional limitation, physical pain, psychological
discomfort, physical disability, psychological dis-
ability, social disability, and handicap. The oral health
ZAP sub-study received specific approval from the
ethical committee of the University Hospital “P.
Giaccone” of Palermo, Italy.
Statistical analysis
The data were tabulated and analyzed accord-
ing to means, standard deviations, and frequency
distributions. Data with normal distribution were
assessed using the Shapiro-Wilk test and analyzed
with the t-test or one-way ANOVA; non-parametric
tests (e.g., Kruskall-Wallis) were also used. Dunn’s
post-hoc test was applied to test pairwise multiple
comparisons. This correction generates the adjusted
p-value which compensates for a p-value increase
by testing each hypothesis at a significance level
of alpha over the number of hypotheses. Chi-square
and Fisher’s exact tests were used to test marginal
associations between qualitative variables. A Pois-
son regression model was applied to model the DMFT
total score related to demographic, clinical, biochem-
ical/genetic, and dental characteristics among the
three studied groups. A backward stepwise selection
process with a lowering of the Akaike information
criterion (AIC) for model selection was used. The
data were analyzed using R software (version 3.5.1);
a p-value lower than 0.05 was considered statistically
significant.
RESULTS
Clinical features, comorbidity, and
biochemical/genetic parameters
The demographic, clinical, biochemical, and
genetic characteristics for CONS, aMCI, and AD are
shown in Table 1. Overall, 55% of participants were
female and the mean age of the subjects was 80 ± 8.68
years, without any significant differences between the
groups, although AD subjects were slightly older than
aMCI and CONS. The overall sample had a mean
year of educational level of 4.81 ± 3.01, without sig-
nificant difference between the groups. Clinically,
the subjects with AD had a significantly longer
disease duration than aMCI (p < 0.01). One-way
ANOVA revealed a significant ADL and IADL effect
between groups (p < 0.01 for both comparisons).
After Dunn’s post hoc comparison, participants with
AD reported a statistically higher number of ADL
lost than aMCI and CONS (adjusted p < 0.001 for
both comparisons), while the latter did not differ
from the former. Similarly, AD showed a significantly
higher number of IADL lost than aMCI and CONS
(adjusted p < 0.001 for both comparisons), without
any difference between the former and the latter. As
expected, ANOVA showed a significant MMSE effect
between groups (p < 0.01). After post-hoc analysis,
AD showed a significantly lower MMSE score than
aMCI and CONS (adjusted p < 0.001 for both com-
parisons), with the former performing worse than
the latter (adjusted p < 0.001). Finally, no differences
regarding depressive symptoms among the groups
were observed. Concerning lifestyles and comorbid-
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Table 1
Demographic, clinical, biochemical, and genetic characteristics of controls (CONS), amnestic mild cognitive impairment (aMCI), and
Alzheimer’s disease (AD)∗
CONS n = 20 aMCI n = 20 AD n = 20 p Post-hoc
Demographics
Age, y 78.8 ± 8.1 78.0 ± 9.5 83.5 ± 7.7 0.09 n.s.
Education, y 5.5 ± 2.8 4.7 ± 3.9 4.3 ± 2.0 0.11 n.s.
Female, n (%) 12 (60) 9 (45) 12 (60) 0.54 n.s.
Clinical characteristics
Disease duration, y n.a. 1.75 ± 0.85 5.05 ± 3.36 <0.01 AD>aMCI
ADL lost 0.25 ± 0.44 0.45 ± 0.51 2.7 ± 2.15 <0.01 AD>CONS, AD> aMCI
IADL lost 0.45 ± 0.75 1.15 ± 0.87 5.15 ± 1.78 <0.01 AD>CONS, AD> aMCI
MMSE 26.71 ± 1.28 24.26 ± 1.45 16.03 ± 6.49 <0.01 AD<aMCI<CONS
CES-D 13.3 ± 9.38 16.75 ± 9.01 17.3 ± 9.17 0.33 n.s.
Lifestyles and Comorbidity
Alcohol, n (%) 3 (15) 4 (20) 3 (15) 1 n.s.
Smoking, n (%) 4 (20) 2 (10) 0 (0) 0.15 n.s.
Hypertension, n (%) 12 (60) 13 (65) 15 (75) 0.59 n.s.
Dyslipidemia, n (%) 7 (35) 5 (25) 6 (30) 0.78 n.s.
Diabetes, n (%) 4 (20) 3 (15) 3 (15) 1 n.s.
Atrial Fibrillation, n (%) 1 (5) 3 (15) 2 (10) 0.86 n.s.
IHD, n (%) 0 (0) 6 (30) 2 (1) 0.02 -
Obesity, n (%) 2 (10) 4 (20) 4 (20) 0.74 n.s.
BMI 27 ± 2.69 27.50 ± 4.00 26.35 ± 5.07 0.66 n.s.
Biochemical and Genetic parameters
hs-CRP mg/L 0.30 ± 0.24 0.55 ± 0.77 0.45 ± 0.47 0.92 n.s.
APOE4 allele, n (%) 0 (0) 1 (5) 3 (15) 0.48 n.s.
∗Except were specified data are expressed as mean ± SD. ADL, Activities of Daily Living; IADL, Instrumental Activities of Daily Living;
MMSE, Mini-Mental State Examination; CES-D, Center for Epidemiologic Studies - Depression scale; IHD, ischemic heart disease; BMI,
body mass index; hs-CRP, high sensitivity C-reactive protein; APOE4, Apolipoprotein E, 4 allele; n.s., not significant.
Table 2
DMFT scores and dental characteristics of controls (CONS), amnestic mild cognitive impairment (aMCI), and Alzheimer’s disease (AD)∗
Index CONS n = 20 aMCI n = 20 AD n = 20 p Post-hoc
DMFT total score 19.7 ± 5.88 21 ± 6.45 25.85 ± 7.25 0.01 AD>CONS, AD> aMCI
D 2.6 ± 2.01 2.1 ± 1.58 2.3 ± 1.21 0.62
M 14.7 ± 5.75 15.55 ± 6.96 22.05 ± 7.09 <0.001 AD>CONS, AD> aMCI
F 2.4 ± 1.95 3.35 ± 3.06 1.4 ± 1.63 0.05 n.s.
DMFT by gender
Men 23.25 ± 4.97 21.54 ± 6.28 27.5 ± 4.20 0.07 n.s.
Women 17.33 ± 5.36 20.33 ± 6.98 24.75 ± 8.73 0.05 n.s.
Dental characteristics, n (%)
BoP (Yes versus No) 12 (60) 14 (70) 8 (40) 0.11 n.s.
Tooth mobility (Yes versus No) 9 (45) 10 (50) 5 (25) 0.25 n.s.
Orofacial pain (Yes versus No) 5 (25) 3 (15) 2 (10) 0.57 n.s.
Dental abscess (Yes versus No) 3 (15) 1 (5) 0 (0) 0.31 n.s.
Halitosis (Yes versus No) 7 (35) 8 (40) 3 (15) 0.20 n.s.
Calculus (Yes versus No) 15 (75) 13 (65) 9 (45) 0.18 n.s.
∗Except were specified data are expressed as mean ± SD. DMFT, decaying (D), missing (M) and filled (F) teeth index; BoP, bleeding on
probing; n.s., not significant.
ity, smoking habits and alcohol consumption did not
significantly differ between groups and nor did vas-
cular/metabolic comorbidities in the study groups.
The results of biochemical and genetic parame-
ters did not differ across the groups although the
APOE4 allele was slightly more frequent in the
AD group.
Dental status, periodontal condition, oral
bacterial load, and OHR-QoL
Table 2 shows DMFT scores and dental charac-
teristics of CONS, aMCI, and AD. ANOVA revealed
significant differences among the means of the DMFT
total score in the three groups (p = 0.01). After
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Table 3
Periodontal indexes and oral microbial load of controls (CONS), amnestic mild cognitive impairment (aMCI), and Alzheimer’s disease
(AD)∗
Index CONS n = 20 aMCI n = 20 AD n = 20 p Post-hoc
CPI score 2.25 ± 1.01 2.3 ± 0.86 2.1 ± 1.02 0.89 n.s.
PSR score 2.45 ± 0.94 2.3 ± 0.86 2.3 ± 1.03 0.91 n.s.
Periokit
A.a. 650.0 ± 1,436.55 9,525.0 ± 18,494.15 3,840.0 ± 11,648.96 0.39 n.s.
F.n. 112,893.5 ± 337,665.3 98,525.0 ± 224,955.9 303,898.5 ± 602,829.7 0.04 AD>CONS
P.g. 651,770.0 ± 2,167,330.0 329,770.0 ± 1,360,371.0 767,551.0 ± 3,117,436.0 0.57 n.s.
P.i. 88,075.0 ± 174,243.6 73,410.0 ± 140,511.9 12,405.0 ± 36,071.0 0.12 n.s.
T.d. 297,343.5 ± 760,184.7 336,138.5 ± 792,205.6 55,678.5 ± 189,176.7 0.01 aMCI>AD
T.f. 421,665.0 ± 629,904.8 619,805.0 ± 1,233,501.0 775,950.0 ± 1,281,404.0 0.45 n.s.
Total bacterial load 33,213,500.0 ± 47,987,316.0 32,584,500.0 ± 50,686,251.0 57,945,000.0 ± 103,570,760.0 0.36 n.s.
∗Data are expressed as mean ± SD. CPI, community periodontal index; PSR, Periodontal Screening and Recording; A.a., Aggregati bacter
Actinomycetemcomitans; F.n., Fusobacterium Nucleatum; P.g., Porphyromonas Gingivalis; P.i., Prevotella intermedia; T.d., Treponema
denticola; T.f., Tannerella forsythia; n.s., not significant.
Table 4
OHIP-14 domains for the controls (CONS), amnestic mild cognitive impairment (aMCI), and Alzheimer’s disease (AD)∗
OHIP-14 domains CONS n = 20 aMCI n = 20 AD n = 20 p
1. Functional limitation (items 1–2) 1.45 ± 1.87 1.30 ± 1.94 1.90 ± 2.40 0.82
2. Physical pain (items 3–4) 2.35 ± 2.81 1.95 ± 1.73 1.65 ± 2.10 0.69
3. Psychological discomfort (items 5–6) 2.1 ± 2.65 1.15 ± 1.66 1.20 ± 1.96 0.43
4. Physical disability (items 7–8) 1.45 ± 1.73 1.05 ± 1.66 1.30 ± 1.52 0.56
5. Psychological disability (items 9–10) 1.80 ± 2.19 0.85 ± 1.31 0.95 ± 1.35 0.34
6. Social disability (items 11–12) 1.35 ± 1.63 0.55 ± 0.99 0.45 ± 1.05 0.08
7. Handicap (items 13–14) 1.45 ± 2.03 0.75 ± 1.33 0.55 ± 1.09 0.14
∗Data are expressed as mean ± SD. OHIP, Oral Health Impact Profile.
post-hoc analysis patients with AD displayed a signif-
icantly higher DMFT total score than aMCI (adjusted
p = 0.009) and CONS (adjusted p = 0.001), while the
latter two groups did not significantly differ from each
other. As a specific sub-item of the DMFT score, the
“M” component (representing the number of miss-
ing teeth) significantly differed among the groups
after ANOVA (p < 0.001). The AD group showed
higher “M” values at pair comparison than the aMCI
(adjusted p < 0.001) and CONS (adjusted p < 0.001),
with no differences between aMCI and CONS. How-
ever, no significant differences were observed for the
other components of the DMFT score (i.e., D and
F, which assess decayed and filled teeth respectively)
and other oral parameters (i.e., bleeding or BoP, tooth
mobility, orofacial pain, dental abscess, halitosis, and
calculus).
The periodontal indexes and oral microbial load
data are shown in Table 3. The scores of the CPI and
PSR indexes did not statistically differ among the
groups. There were no statistically significant differ-
ences with the total oral microbial load of the three
groups although groups differed when comparing
specific bacterial loads, thereby revealing significant
intergroup differences for F.n. and T.d. Specifically,
one-way ANOVA revealed that F.n. load significantly
differed between the groups (p = 0.04), and a post-
hoc analysis revealed a higher F.n. load in AD than
CONS (adjusted p = 0.02). However, the T.d. load dif-
fered significantly between the groups after ANOVA
(p = 0.01), with a post-hoc analysis revealing a higher
T.d. load in aMCI than AD (adjusted p = 0.004. There
were no statistically significant differences in all
the OHIP-14 domains among the three groups (see
Table 4).
Relationships between cognitive impairment and
poor-oral health
Table 5 shows the estimated regression coeffi-
cients, standard errors and p-values for the Poisson
regression model, where the covariates were selected
through the stepwise AIC procedure. The selected
model comprised the following covariates: sex, age,
group (AD or MCI), ADL lost, diabetes, calculus,
BoP, and halitosis. The response variable was the
DMFT total score. The subject baseline status was
male without cognitive impairment, diabetes, halito-
sis, calculus, and BoP. The effect of gender (female
versus male) on the DMFT was significant, and the
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Table 5
Results from Poisson regression analysis∗
Estimate Std. Error z value p
Intercept 2.117 0.344 6.139 <0.001
Sex (Female versus Male) –0.179 0.057 –3.138 0.001
Age 0.014 0.004 3.570 <0.001
AD 0.214 0.085 2.521 0.001
aMCI 0.016 0.073 0.221 0.825
ADL lost –0.037 0.022 –1.666 0.09
Diabetes (Yes versus No) –0.220 0.081 –2.693 0.007
Calculus (Yes versus No) –0.244 0.095 2.547 0.010
BoP (Yes versus No) 0.203 0.098 2.070 0.038
Halitosis (Yes versus No) –0.215 0.079 –2.714 <0.001
∗The outcome variable was DMFT total score; covariates were
selected with a backward stepwise selection process and a lower-
ing of the Akaike information criterion. AD, Alzheimer’s disease;
aMCI, amnestic mild cognitive impairment; ADL, Activities of
Daily Living; BoP, bleeding on probing.
latter total score was higher for males than females
(p = 0.001). Moreover, age had a positive signifi-
cant effect on the DMFT total score (p < 0.001).
Concerning cognitive impairment, subjects with AD
showed higher DMFT than both aMCI and CONS
(p = 0.001). However, the DMFT total score did not
differ in aMCI and CONS groups. Furthermore, the
effect of diabetes, calculus, BoP, and halitosis, treated
as dichotomous variables (presence versus absence)
was statistically significant for the explanation of
DMFT (p from 0.038 to <0.001), while ADL lost
was not statistically significant. Figure 1 shows the
predicted number of DMFT by groups for subjects
aged between 60 and 100 years. A diagnosis of AD
predicted most of the DMFT score, particularly in
subjects aged 80 years or over. Although the DMFT
score increased with age, CONS had the lowest pre-
dicted value of the DMFT score.
DISCUSSION
This case-control study examined the association
between cognitive impairment and oral health status
in elderly subjects drawn from a population-based
cohort. Dental status, periodontal conditions, and oral
microbial load were assessed in 20 AD subjects, 20
aMCI, and 20 healthy controls, all of whom did not
differ in demographic characteristics. The main find-
ings of this study were: 1) patients with AD showed
poor health status related to chronic periodontitis and
lower DMFT scores than aMCI and CONS; 2) the F.
n. bacterial load was significantly higher in AD than
CONS and a higher T.d. bacterial load was found
when comparing aMCI than AD; 3) no statistically
significant differences were observed in OHR-QoL
Fig. 1. Predicted number of DMFT of subjects with age between
60 and 100 years in controls (CONS), amnestic mild cognitive
impairment (aMCI), and Alzheimer’s disease (AD).
domains among the three study groups; and 4) the
diagnosis of AD predicted tooth loss, particularly in
subjects aged 80 years or over.
The mean age of the AD group was higher in
this study (even if non-statistically significant) than
aMCI and CONS. Similarly, the educational level and
gender distribution of the three groups did not dif-
fer. Concerning disability, AD showed a statistically
significant higher number of ADL and IADL lost
than aMCI and CONS. Moreover, and as expected,
AD showed significant lower global cognitive per-
formance (i.e., MMSE score) than aMCI and CONS,
with the former scoring significantly worse than the
latter. Although AD and aMCI showed a higher
score than CONS in the CES-D these differences
were not significant. The comorbidity and biochem-
ical/genetic parameters of the three study groups
(lifestyles and vascular risk factors/diseases, hs-CRP
levels, and APOE4 allele) did not differ; the latter was
markedly more frequent in AD than aMCI and CONS,
even if due to the small sample included in this study,
results did not reach statistical significance.
The AD neurodegenerative-related process can be
influenced by several modifiable and non-modifiable
risk factors [4]. Of the latter, age has been recog-
nized as one of the most important: the aging process
determines a decline of cognitive functioning, with
a subsequent and significant worsening of dietary
and oral hygiene habits in elderly people [5, 11].
Older subjects usually have reduced access to medi-
cal services, and their caregivers may often not give
due care in maintaining effective oral hygiene proce-
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dures [11, 13]. The development of ADL and IADL
impairment, therefore, lead to a reduction in daily
oral hygiene procedures, leading to an increased risk
of periodontal disease, the major risk factor of tooth
loss in adults.
Several researchers have investigated the associ-
ation between cognitive impairment and oral health
status, with particular attention to chronic periodon-
titis; the direction of this association needs to be
clarified [11, 13, 40–46]. Chen et al. have demon-
strated that periodontitis increased the risk of AD
1.7-fold after 10 years [42]. Iwasaki et al. demon-
strated that severe periodontitis was significantly
associated with an increased risk of subsequent cog-
nitive decline and incident MCI in two prospective
studies [45, 46]. Similarly, Nilsson et al. reported that
subjects with signs of periodontitis reported lower
MMSE scores than subjects without [44].
Periodontitis is an infectious bacterial inflamma-
tory disease of the supporting tissue of the teeth,
with gingival bleeding, bone resorption and, subse-
quently, tooth loss. It is caused by local inflammation
supported by periodontal bacteria (e.g., P.g., F.
n., and T.d.). There are two main periodontitis-
associated mechanisms, which are potentially related
to cognitive impairment: 1) an increasing cerebral
inflammation state, caused by a pathological, infec-
tious periodontal process; and 2) direct periodontal
bacteria access to the central nervous system, thereby
potentially triggering preexisting neurodegenerative
pathology [47].
Chronic periodontitis is related to the rise of
blood pro-inflammatory cytokines levels, such as
TNF, IL-6, IL-10, IL-8, and CPR, all of which are
involved in the progression of several chronic dis-
eases, including neurodegenerative disorders [24].
These pro-inflammatory cytokines can induce a sys-
temic inflammation potentially capable of increasing
the production of cerebral cytokines, via olfactory or
trigeminal nerve fibers [47]. A relative increase in
the pro-inflammatory status was demonstrated in AD
patients with periodontitis during a 6-month follow-
up period in the study by Ide et al. [41]. Various
periodontal bacteria have demonstrated the capability
of reaching the central nervous system and infecting
the brain. Some species, such as Porphyromonas or
Treponema, have been found in the trigeminal gan-
glia or in brain specimens of patients affected by AD
[11, 48, 49]. These reports suggest the hypothesis
of a direct bacterial toxic activity on brain cells, in
turn triggering several inflammatory pathways and
reactions which are strictly associated with the degen-
erative process of AD, such as the amyloid deposition
[50].
No statistically significant differences regarding
the total oral microbial load of the studied groups
were found in this research. However, the F.n. load
was significantly higher in AD compared to CONS.
F.n. is a gram-negative anaerobic bacterium with the
ability to survive in high proportions of oxygen. It is
one of the commonest species in the human gingival
sulcus, and it may be isolated both from healthy and
compromised periodontal teeth [51]. F.n. can have
a crucial role in the development and progression
of periodontal disease: its prevalence increases with
the severity of periodontitis, the progression of the
inflammation and the pocket depth [52]. Indeed, it
is a member of the bridging complex with the capa-
bility to co-aggregate with early and late colonizers,
such as P.g. or A.a. and amplifies the damages of
periodontal tissues, thereby favoring the formation
of pathogen biofilms [52–54]. Overall, from the data
discussed above it can be hypothesized that the colo-
nization of the Fusobacterium nucleatum contributed
to the development of a more aggressive periodontal
disease in the AD group, with a consequent increase
in the number of lost teeth compared to the other
groups. Accordingly, these results support a role of
periodontitis in AD development. Indeed, the latter
has a natural history culminating in the loss of den-
tal elements [47]. Accordingly, AD patients in this
study suffered from a marked reduction in the num-
ber of teeth and higher DMFT scores than aMCI
and CONS.
The evaluation of the oral microbial load has also
revealed a higher load of T.d. in the aMCI group com-
pared to AD. This result may be due to the fact that the
distribution of oral treponema is usually not uniform
within the dentition or around individual teeth, with
high inter-individual variability [47]. Although T.d.
is more likely to occur in patients with periodontitis
than in healthy subjects, it has been demonstrated
that plaque from most diseased sites and nearby
healthy sites did not always contain detectable lev-
els of spirochetes [55]. Furthermore, the assessment
of oral bacterial load did not reveal any significant
difference in P.g. load between groups. The latter is
considered a keystone pathogen in the development of
chronic periodontitis and has been found in AD brains
[56]. These data further confirm that oral bacteria may
escape the periphery and access the brain of patients
with dementia. Interestingly, and substantially in line
with the results of this study, recent research has
not revealed any significant differences in the lev-
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els of antibodies against selected bacteria (including
T.d. and P.g.) in the serum and cerebrospinal fluid of
subjects between the groups, particularly in AD [57].
No statistically significant differences were
observed regarding the periodontal indexes (i.e., CPI
and PSR scores) of the three groups. Similarly, there
were no statistically significant differences in the
OHIP-14 domains between groups. Overall, these
results probably reflect the relatively small sample
of subjects included in this research and the cross-
sectional study design, which were unable to detect
the dynamic periodontal process of the enrolled
patients. Of interest, a recent systematic review of
the association of OHR-QoL of life in AD reported a
statistically significant difference between AD and
controls only in one study, while others did not
describe any differences [58]. These finding suggest
that AD patients have reduced ability in reporting oral
health complaints using a self-filled questionnaire
such as the OHIP-14 due to cognitive impairment, and
further tools are required to improve the evaluation
of OHR-QoL in subjects with dementia.
In conclusion, case-control studies have evaluated
the relationship between AD and periodontitis but the
results were inconclusive due to the wide heterogene-
ity in the studies performed and their methodologies.
Some studies were hospital-based [46, 59, 60] and
others were based on population-based cohorts [42,
43, 61]. Furthermore, the majority of studies were
retrospective cohorts [42, 46, 60, 61] with only a few
being classified as prospective cohort [60]. Conse-
quently, the hospital-based data collection and the
retrospective study design may have introduced a
selection bias, a misclassification or information bias,
thus not representing the exposure experience of
the true source population [60]. Furthermore, the
authors of the aforementioned studies applied a wide
heterogeneity of evaluation methods regarding the
diagnosis of cognitive impairment (e.g., use of global
cognitive measures, ICD diagnoses, clinical crite-
ria) and chronic periodontitis (e.g., clinical diagnosis,
standardized tools, oral microbial load) [47].
In order to reduce this heterogeneity, the authors
of this study performed a population-based case-
control study with an inherent reduction in selection
bias. Moreover, a comprehensive oral health status
assessment was conducted, including several stan-
dardized clinical tools and the evaluation of oral
microbial load. Nonetheless, several limitations of
this study should be considered. First, aMCI and AD
were diagnosed according to clinical criteria, in the
absence of the biomarkers of neurodegeneration or
postmortem confirmation, leading to issues of diag-
nostic uncertainty. In order to reduce this problem, a
multidimensional clinical and cognitive protocol was
used, and the clinical classification was supported
by 1.5 T MRI imaging to exclude vascular cogni-
tive impairment. Second, a relatively small sample
size of subjects was included in this research. This
might increase the likelihood of spurious associations
and a lack of significance (e.g., in some OHIP-14
domain mean scores of aMCI and AD were clearly
lower than in CONS). Third, residual confounding
cannot be excluded, and mechanisms independent
of periodontitis (e.g., others comorbidities, diffi-
culty in accessing dental care) could be associated
with tooth loss in people with dementia. Lastly, the
cross-sectional study design precludes making causal
inferences about the relationship between periodon-
titis and the study outcomes (aMCI and AD).
In conclusion, in this study AD was associated
with the presence of chronic periodontitis and tooth
loss, possibly via a low-grade systemic inflamma-
tion due to F.n. Prospective ZAP data and that from
other population-based cohorts are required to clarify
the role of periodontitis as a risk factor for AD and
dementia. These data would have relevant implication
for the treatment of AD and its prevention.
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